Literature DB >> 24146040

Heparan sulfate in angiogenesis: a target for therapy.

Xander M R van Wijk1, Toin H van Kuppevelt.   

Abstract

Heparan sulfate (HS), a long linear polysaccharide of alternating disaccharide residues, interacts with a wide variety of proteins, including many angiogenic factors. The involvement of HS in signaling of pro-angiogenic factors (e.g. vascular endothelial growth factor and fibroblast growth factor 2), as well as interaction with anti-angiogenic factors (e.g. endostatin), warrants its role as an important modifier of (tumor) angiogenesis. This review summarizes our current understanding of the role of HS in angiogenic growth factor signaling, and discusses therapeutic strategies to target HS and modulate angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24146040     DOI: 10.1007/s10456-013-9401-6

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  20 in total

Review 1.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

Review 2.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

3.  Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.

Authors:  Daniel R Sandoval; Alejandro Gomez Toledo; Chelsea D Painter; Ember M Tota; M Osman Sheikh; Alan M V West; Martin M Frank; Lance Wells; Ding Xu; Roy Bicknell; Kevin D Corbett; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

4.  A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3).

Authors:  Xander M van Wijk; Roger Lawrence; Victor L Thijssen; Sebastiaan A van den Broek; Ran Troost; Monique van Scherpenzeel; Natasha Naidu; Arie Oosterhof; Arjan W Griffioen; Dirk J Lefeber; Floris L van Delft; Toin H van Kuppevelt
Journal:  FASEB J       Date:  2015-04-13       Impact factor: 5.191

5.  A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells.

Authors:  John Baldwin; Erika Maus; Brian Zanotti; Michael V Volin; Ritesh Tandon; Deepak Shukla; Vaibhav Tiwari
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

Review 6.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

7.  Induction of initial steps of angiogenic differentiation and maturation of endothelial cells by pericytes in vitro and the role of collagen IV.

Authors:  Zhigang Zhou; Friederike Pausch; Ursula Schlötzer-Schrehardt; Bent Brachvogel; Ernst Pöschl
Journal:  Histochem Cell Biol       Date:  2016-01-09       Impact factor: 4.304

8.  The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors.

Authors:  Sumeda Nandadasa; Anna O'Donnell; Ayako Murao; Yu Yamaguchi; Ronald J Midura; Lorin Olson; Suneel S Apte
Journal:  Matrix Biol       Date:  2021-01-14       Impact factor: 11.583

9.  Role of chondroitin sulfate in the developmental and healing process of the dental pulp in mice.

Authors:  Hiroko Ida-Yonemochi; Kosei Takeuchi; Hayato Ohshima
Journal:  Cell Tissue Res       Date:  2022-01-24       Impact factor: 5.249

Review 10.  Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response.

Authors:  Mannon Geindreau; François Ghiringhelli; Mélanie Bruchard
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.